Cargando...
Aprepitant for gefitinib-induced refractory pruritus in Chinese malignancy population
Targeted therapy is an important anti-cancer therapy in non-small cell lung cancer (NSCLC). Pruritus are the common side-effect with gefitinib, an anti-EGFR antibody and tyrosine-kinase inhibitor. We reported case reports to confirm the effects of aprepitant, a neurokinin receptor to management of r...
Gardado en:
| Publicado en: | Ann Transl Med |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AME Publishing Company
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6389580/ https://ncbi.nlm.nih.gov/pubmed/30906758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.01.02 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|